Fujian Yango $110 Million High-Yield Notes Offering
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $110 million principal amount of 11.875% senior notes due 2020 by Yango (Cayman) Investment…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Primary Placing of Shares in GCL-Poly Energy Holdings Limited
Davis Polk advised the placing agent for the primary placement of up to 1,511,000,000 shares in GCL-Poly Energy Holdings Limited for a total consideration of approximately HK$680 million…
Davis Polk Advises Tencent on Its $6 Billion Notes Offering Under Its Global MTN Program
Davis Polk advised Tencent Holdings Limited as English and U.S. law counsel in connection with the upsize and update of its $20 billion global medium-term note program and the offering…
Davis Polk Advises Tencent Holdings Limited on Its HK$353 Million Purchase of Weimob Inc. Shares
Davis Polk advised Tencent Holdings Limited in connection with its purchase of 96,820,000 ordinary shares of Weimob Inc. for an aggregate purchase price of HK$353 million.
Before the…
Tencent Holdings HK$550 million subscription of China Youzan shares
Davis Polk advised Tencent Holdings Limited in connection with its subscription of 1,036,766,038 ordinary shares of China Youzan Limited for an aggregate subscription price of HK$550…
China South City Holdings Limited $200 Million Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a $200 million Regulation S only offering by China South City Holdings Limited of its 11.875% senior notes due 2021.
CSC is a…
Davis Polk Advises CStone Pharmaceuticals on Its HK$2.24 Billion (US$285.05 Million) Initial Public Offering
Davis Polk advised CStone Pharmaceuticals in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…
AsiaInfo Technologies Limited HK$865.3 Million (US$110.6 Million) Initial Public Offering
Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S of…
Innovent Biologics, Inc. HK$3.15 Billion (US$403.1 Million) Initial Public Offering
Davis Polk advised the underwriters and joint global coordinators in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on…
BeiGene Ltd. HK$7.08 Billion (US$903 Million) Public Offering on the Hong Kong Stock Exchange
Davis Polk advised the underwriters and the joint global coordinators in the public offering of BeiGene, Ltd. on the Hong Kong Stock Exchange. The gross proceeds from the offering…